Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Xbrane Biopharma

6.01 SEK

-1.30 %

Less than 1K followers

XBRANE

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xbrane Biopharma

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue66.865.8198.793.239.910.19.1152.4
EBITDA-37.458.5-127.732.6-7.7-20.7-21.9-13.6
EBIT-37.4-31.7-217.927.7-7.7-23.5-24.7-28.2
EBIT-%-56.0 %-48.2 %-109.7 %29.7 %-19.3 %-232.6 %-271.4 %-18.5 %
Profit before taxes-44.8-41.3-253.419.3-13.3-23.7-26.2-43.9
Net income-45.1-53.2-266.28.2169.6-24.0-26.5127.2
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.